BPC-157 modulates nitric oxide synthase (NOS) activity, specifically reducing inducible NOS (iNOS) expression triggered by inflammatory injury while preserving endothelial NOS (eNOS) activity needed for vascular integrity
CMS provides hospitals the opportunity to preview their Overall Hospital Quality Star Rating prior to publication
Among 169,649 patients with MASLD, GLP-1 receptor agonist initiation was linked to significantly lower probability of incident cirrhosis [adjusted hazard ratio (aHR): 0.86, 95%CI: 0.80-0.93], hepatic decompensation (aHR: 0.77, 95%CI: 0.65-0.90), and hepatocellular carcinoma (HCC) (aHR: 0.79, 95%CI: 0.68-0.92) over a median follow-up of 3.5 years compared to non-users
touringsedan July 31, 2025, 9:02pm #32 SS-31 repairs the DNA, not sure if it was meant to be lumped with uncouplers
Her expertise in identifying allergens and recommending appropriate treatments was remarkable